Ptc Therapeutics (PTCT) Cash & Equivalents (2012 - 2026)
Ptc Therapeutics' Cash & Equivalents came in at $508.89 million for Q3 2026, down 24.3% from $672.62 million a year earlier and down 51.5% from the prior quarter.
Powered by 
Analysis
Ptc Therapeutics (PTCT) Cash & Equivalents (2012 - 2026) Analysis & Trends
At the end of FY2025, Ptc Therapeutics' Cash & Equivalents was $984.65 million, up 26.3% from FY2024.
- Cash & Equivalents has increased in each of the last four years, with a five-year compound annual growth rate of 36.4% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $779.71 million in FY2024 (+31.3%), $594 million in FY2023 (+112.3%), $279.83 million in FY2022 (+47.5%) and $189.72 million in FY2021 (-9.1%).
- The Q3 2026 figure represents the lowest quarterly Cash & Equivalents since Q3 2023.
- Year-over-year, Cash & Equivalents increased in six of the last eight quarters, with growth averaging 30.7%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2024 (growth of 227.4%), and the weakest in Q3 2022 (a decline of 45.0%).
- Business Quant data shows PTCT's Cash & Equivalents at $1.05 billion (Q2 2026), $833.99 million (Q1 2026) and $984.65 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Ptc Therapeutics | 5.36 Bn | -2.84 Bn | 334.14 Mn | 508.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 508.89 Mn |
| Jun 30, 2026 | 1.05 Bn |
| Mar 31, 2026 | 833.99 Mn |
| Dec 31, 2025 | 984.65 Mn |
| Sep 30, 2025 | 672.62 Mn |
| Jun 30, 2025 | 1.02 Bn |
| Mar 31, 2025 | 1.48 Bn |
| Dec 31, 2024 | 779.71 Mn |
| Sep 30, 2024 | 526.00 Mn |
| Jun 30, 2024 | 654.78 Mn |
| Mar 31, 2024 | 548.36 Mn |
| Dec 31, 2023 | 594.00 Mn |
| Sep 30, 2023 | 165.16 Mn |
| Jun 30, 2023 | 208.39 Mn |
| Mar 31, 2023 | 167.50 Mn |
| Dec 31, 2022 | 279.83 Mn |
| Sep 30, 2022 | 104.42 Mn |
| Jun 30, 2022 | 158.16 Mn |
| Mar 31, 2022 | 144.18 Mn |
| Dec 31, 2021 | 189.72 Mn |
API Access
Ptc Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PTCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PTCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PTCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();